Rapid growth of acquired UBA1 mutations predisposes male patients to low-risk MDS

被引：0

作者：

Li, Peng ^{[1
,2
]}

Alnoor, F. N. U. ^{[1
,3
]}

Xie, Wei ^{[4
]}

Williams, Margaret ^{[1
,2
]}

Feusier, Julie ^{[1
,2
]}

Ding, Yi ^{[5
]}

Zhao, Xiangrong ^{[6
]}

Zheng, Gang ^{[7
]}

Zhao, Chen ^{[8
]}

Zieske, Arthur W. ^{[9
]}

Zu, Youli ^{[9
]}

Raess, Philipp W. ^{[4
]}

Tantravahi, Srinivas ^{[10
,11
]}

Osman, Afaf ^{[10
,11
]}

Patel, Ami B. ^{[10
,11
]}

Tashi, Tsewang ^{[10
,11
]}

Patel, Jay L. ^{[1
,2
]}

Matynia, Anna P. ^{[1
,2
]}

Menon, Madhu P. ^{[1
,2
]}

Miles, Rodney R. ^{[1
,2
,11
]}

Jacobsen, Jeffrey R. ^{[1
,2
]}

George, Tracy I. ^{[1
,2
,11
]}

Sborov, Douglas W. ^{[10
,11
]}

Szankasi, Philippe ^{[2
]}

Rindler, Paul ^{[2
]}

Close, Devin ^{[2
]}

Ohgami, Robert S. ^{[1
,2
]}

机构：

[1] Univ Utah Hlth, Dept Pathol, Salt Lake City, UT 84132 USA

[2] ARUP Labs, Salt Lake City, UT 84108 USA

[3] Washington Univ, Dept Pathol & Immunol, St Louis, MO USA

[4] Oregon Hlth & Sci Univ, Sch Med, Dept Pathol & Lab Med, Portland, OR USA

[5] Geisinger Med Ctr, Lab Med, Danville, PA USA

[6] Kaiser Permanente, Sacramento, CA USA

[7] Mayo Clin Labs, Rochester, MN USA

[8] Case Western Reserve Univ, Dept Pathol & Lab Med, Cleveland, OH USA

[9] Houston Methodist Hosp, Pathol & Genom Med, Houston, TX USA

[10] Univ Utah Hlth, Dept Internal Med, Salt Lake City, UT USA

[11] Huntsman Canc Inst, Salt Lake City, UT USA

来源：

LEUKEMIA | 2025年 / 39卷 / 01期

关键词：

D O I：

10.1038/s41375-024-02397-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：248 / 256

页数：9

共 50 条

[21] Absence of NLRP3 somatic mutations and VEXAS-related UBA1 mutations in a large cohort of patients with Schnitzler syndrome
Louvrier, Camille
Awad, Fawaz
Amselem, Serge
Lipsker, Dan
Giurgea, Irina
ALLERGY, 2022, 77 (11) : 3435 - 3436
[22] HEMATOPOIETIC GROWTH-FACTOR THERAPY FOR PATIENTS WITH MYELODYSPLASIA AT LOW-RISK FOR LEUKEMIA (MDS-LR)
WILLEMZE, R
BRITISH JOURNAL OF HAEMATOLOGY, 1992, 82 (01) : 236 - 236
[23] Low-risk MDS; transfusion therapy, growth factors and the European view on lenalidomide
Hellstrom-Lindberg, E.
LEUKEMIA RESEARCH, 2009, 33 : S26 - S27
[24] Low-risk patients admitted with community-acquired pneumonia
Marrie, TJ
Huang, JQ
AMERICAN JOURNAL OF MEDICINE, 2005, 118 (12): : 1357 - 1363
[25] ASXL1 Mutations Predict a Poor Response to Darbepoetin Alfa in Anemic Patients with Low-Risk MDS: A Multicenter, Phase II Study
Hanamoto, Hitoshi
Morita, Yasuyoshi
Ichikawa, Motoshi
Nannya, Yasuhito
Shibayama, Hirohiko
Maeda, Yoshinobu
Hata, Tomoko
Miyamoto, Toshihiro
Kawabata, Hiroshi
Takeuchi, Kazuto
Tanaka, Hiroko
Kishimoto, Junji
Miyano, Satoru
Matsumura, Itaru
Ogawa, Seishi
Akashi, Koichi
Kanakura, Yuzuru
Mitani, Kinuko
BLOOD, 2020, 136
[26] DEREGULATION OF THE TRANSFORMING GROWTH FACTOR-B PATHWAY IN LOW-RISK MDS PATIENTS SF3B1 MUTATED
Cristiano, A.
Silvestrini, G.
Hajrullaj, H.
Galossi, E.
Falconi, G.
Palmieri, R.
Hutter, S.
Nadarajah, N.
Gumenyuk, S.
Buccisano, F.
Fenu, S.
Latagliata, R.
Haferlach, T.
Voso, M. T.
Fabiani, E.
HAEMATOLOGICA, 2022, 107 : 13 - 14
[27] Characteristics of low-risk patients hospitalized with community-acquired pneumonia
Etzion, O.
Novack, V.
Avnon, L.
Porath, A.
Dagan, E.
Riesenberg, K.
Avriel, A.
Schlaeffer, F.
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2007, 18 (03) : 209 - 214
[28] Excellent Prognosis of Low-Risk Myelodysplastic Syndromes (MDS) Without Detectable Myeloid-Related Mutations
Polprasert, Chantana
Niparuck, Pimjai
Rattanathammethee, Thanawat
Chuncharunee, Suporn
Kobbuaklee, Sirorat
Songserm, Kritanan
Suksusut, Amornchai
Trithiphen, Sasinipa
Lanamtieng, Theerin
Kongkiatkamon, Sunisa
Chanswangphuwana, Chantiya
Lawasut, Panisinee
Bunworasate, Udomsak
Rojnuckarin, Ponlapat
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (05): : E293 - E299
[29] LOW-RISK MYELODYSPLASTIC SYNDROMES (MDS) WITHOUT MUTATIONS ARE AS GOOD AS IDIOPATHIC CYTOPENIA OF UNDETERMINED SIGNIFICANCE (ICUS)
Polprasert, C.
Niparuck, P.
Rattanathammethee, T.
Chuncharunee, S.
Kobbualkee, S.
Songserm, K.
Suksusut, A.
Trithiphen, S.
Lanamtieng, T.
Kongkiatkamon, S.
Bunworasate, U.
Rojnuckarin, P.
LEUKEMIA RESEARCH, 2021, 108 : S14 - S14
[30] Effect of Erythropoietin Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients.
Follo, Matilda Y.
Mongiorgi, Sara
Clissa, Cristina
Chiarini, Francesca
Paolini, Stefania
Baccarani, Michele
Martinelli, Giovanni
Manzoli, Lucia
Martelli, Alberto M.
Finelli, Carlo
Cocco, Lucio
BLOOD, 2009, 114 (22) : 941 - 942

← 1 2 3 4 5 →